AMLo Biosciences

0 followers

‌

Formed in late 2017, AMLo Biosciences is dedicated to providing a prognostic test for early AJCC Stage I and Stage II melanoma to better identify patients’ true risk of disease progression.

Industries

Biotechnology

Headquarters

Newcastle upon Tyne, United Kingdom

Employees

11-50

Links

Org chart

Marie Labus

Chief Executive Officer

Marie Labus

Collapse

Penny Lovat

Chief Scientific Officer

Akhtar Husain

Chief Medical Officer

Jane Meaney

Chief Marketing Officer

Philip Sloan

Chief Histopathologist

Sarah Cockman

Quality Assurance & Regulatory Affairs Manager

Grant Richardson

Technical Manager

Catherine Graham

Project Manager

Helen Pearse

Systems Administrator

Robert Smith

Lab Technician

Teams

Leadership Team

4 members

Medical and Scientific Professionals

5 members

Similar companies

Queen Mary University

5 followers

Xylyx Bio

1 follower

Oxford Nanopore Technologies

6 followers

Calico

6 followers

Oxford BioMedica

2 followers

Neogene Therapeutics

2 followers

FUJIFILM Diosynth Biotechnologies

5 followers

The Academy of Medical Sciences

1 follower

Capricor Therapeutics

1 follower

Cartesian Therapeutics

1 follower

HiberCell

1 follower

Explore companies

��������